Literature DB >> 2859530

Preferential antagonism by diltiazem of alpha 2-adrenoceptor mediated vasoconstrictor responses in perfused tail arteries of spontaneous hypertensive rats.

P E Hicks, C Tierney, S Z Langer.   

Abstract

Vasoconstrictor responses mediated by the alpha 2-adrenoceptor agonist TL99, were particularly sensitive to blockade by the calcium antagonist drug diltiazem in isolated perfused tail arteries of spontaneously hypertensive rats (SHR). In contrast, the vasoconstrictor responses induced by the alpha 1-adrenoceptor agonist methoxamine were significantly more resistant to antagonism by diltiazem. At higher concentrations (greater than 300 nmol/l) diltiazem became an effective antagonist of all alpha-adrenoceptor mediated responses. In normotensive Wistar Kyoto (WKY) or Sprague-Dawley (SD) rats diltiazem was significantly less potent against vasoconstrictor responses to TL99 than in SHR. The blockade of alpha 1-adrenoceptor mediated vasoconstriction by diltiazem was not significantly different when normotensive rats and SHR were compared. The vasoconstrictor responses evoked by 5HT in the perfused tail arteries were particularly resistant to blockade by diltiazem in SHR arteries. The responses to endogenously released noradrenaline, evoked by electrical field stimulation, were significantly antagonised by diltiazem (30 nmol/1-3 mumol/l) in SHR-tail arteries, while they were not modified in WKY-tail arteries. At the concentrations of diltiazem which blocked end organ responses to field stimulation, there was no modification of total tritium overflow from SHR-tail arteries after labelling the tissue with 3H-noradrenaline, indicating that diltiazem does not inhibit transmitter release at these concentrations. The tail artery preparation of SHR contains a population of postsynaptic alpha 2-adrenoceptors which mediate contraction in this blood vessel and the calcium entry blocker diltiazem is a potent antagonist of vasoconstrictor responses mediated by vascular alpha 2-adrenoceptors in hypertensive rats. These findings may be relevant to the antihypertensive action of diltiazem.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859530     DOI: 10.1007/bf00692906

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

1.  Inhibitory effects of verapamil, prenylamine and D 600 on Ca2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts.

Authors:  M Göthert; P Nawroth; H Neumeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

2.  Cocaine and amphetamine antagonize the decrease of noradrenergic neurotransmission elicited by oxymetazoline but potentiate the inhibition by alpha-methylnorepinephrine in the perfused cat spleen.

Authors:  S Z Langer; M L Dubocovich
Journal:  J Pharmacol Exp Ther       Date:  1981-01       Impact factor: 4.030

Review 3.  alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs.

Authors:  P B Timmermans; P A van Zwieten
Journal:  J Med Chem       Date:  1982-12       Impact factor: 7.446

4.  Binding of [3H]nitrendipine to heart and brain membranes from normotensive and spontaneously hypertensive rats.

Authors:  K Ishii; T Kano; Y Kurobe; J Ando
Journal:  Eur J Pharmacol       Date:  1983-03-25       Impact factor: 4.432

5.  Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.

Authors:  I C Medgett; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1984-06       Impact factor: 4.030

6.  Characterisation of postjunctional alpha-adrenoceptors in isolated human femoral veins and arteries.

Authors:  E Glusa; F Markwardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

7.  Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.

Authors:  J C Doxey; A G Roach; C F Smith
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

8.  Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

Authors:  I Cavero; N Shepperson; F Lefèvre-Borg; S Z Langer
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

9.  alpha-adrenoreceptor-mediated phasic and tonic activity in rat portal vein in vitro.

Authors:  P E Hicks
Journal:  J Auton Pharmacol       Date:  1983-06

10.  The action of prazosin in human vascular preparations.

Authors:  R A Jauernig; R F Moulds; J Shaw
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-01
View more
  8 in total

1.  Alpha-1 and alpha-2 adrenoceptor agonists induce vasoconstriction of the normotensive rat caudal artery in vitro by stimulation of a heterogeneous population of alpha-1 adrenoceptors.

Authors:  J Atkinson; N Trescases; C Benedek; N Boillat; A K Fouda; F Krause; M C Pitton; C Rafizadeh; J C de Rivaz; M Sautel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

2.  Alpha 2-adrenoceptor agonists enhance vasoconstrictor responses to alpha 1-adrenoceptor agonists in the rat tail artery by increasing the influx of Ca2+.

Authors:  X H Xiao; M J Rand
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

3.  Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.

Authors:  M H Liu; S H Floten; Q Yang; G W He
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

4.  Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery.

Authors:  B Clasbrummel; H Osswald; P Illes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

5.  Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery.

Authors:  G W He; T E Acuff; W H Ryan; C Q Yang; M B Douthit; R T Bowman; M J Mack
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

6.  Greater vasodepressor sensitivity to nicardipine in spontaneously hypertensive rats (SHR) compared to normotensive rats.

Authors:  J Atkinson; M Sautel; M Sonnay; J P Fluckiger; J C de Rivaz; N Boillat; M C Piton; P A Porchet; J M Armstrong; A K Fouda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

7.  Differential effects of alpha-beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries.

Authors:  M Vidal; P E Hicks; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

8.  Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.

Authors:  P E Hicks; M Najar; M Vidal; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.